1. A model for evaluating topical antimicrobial efficacy against methicillin-resistant Staphylococcus aureus biofilms in superficial murine wounds
- Author
-
Dennis L. Carson, Shannon P. Tetens, Paul J. Renick, and Eric Roche
- Subjects
Methicillin-Resistant Staphylococcus aureus ,Meticillin ,medicine.drug_class ,Administration, Topical ,Antibiotics ,Mupirocin ,Biology ,medicine.disease_cause ,Silver sulfadiazine ,Microbiology ,chemistry.chemical_compound ,Mice ,Bacitracin ,medicine ,Animals ,Pharmacology (medical) ,Pharmacology ,integumentary system ,Biofilm ,Silver Compounds ,biochemical phenomena, metabolism, and nutrition ,Antimicrobial ,Methicillin-resistant Staphylococcus aureus ,Silver Sulfadiazine ,Infectious Diseases ,chemistry ,Staphylococcus aureus ,Biofilms ,Anti-Infective Agents, Local ,Wound Infection ,medicine.drug - Abstract
A wound biofilm model was created by adapting a superficial infection model. Partial-thickness murine wounds were inoculated with methicillin-resistant Staphylococcus aureus (MRSA). Dense biofilm communities developed at the wound surface after 24 h as demonstrated by microscopy and quantitative microbiology. Common topical antimicrobial agents had reduced efficacy when treatment was initiated 24 h after inoculation compared to 4 h after inoculation. This model provides a rapid in vivo test for new agents to treat wound biofilm infections.
- Published
- 2012